Drug Policy Reform

Drug policy frameworks decisively shape clinical outcomes and population mortality. The session covers decriminalisation outcomes from Portugal's two decades of experience, the Oregon Measure 110 reversal and lessons, British Columbia's safer supply experiment, supervised consumption sites in Vancouver and New York, drug-checking legalisation, sentencing reform and the post-2024 federal landscape, and the international harm-reduction framework under UNODC and WHO. Discussion addresses involuntary-treatment expansion across California and Washington, the political economy of drug policy in election years, and country-specific responses to the global fentanyl supply across Latin America, Europe and South-East Asia.